Cargando…
Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer
Pancreatic cancer accounts for nearly one fourth of all new cancers worldwide. Little progress in the development of novel or adjuvant therapies has been made over the past few decades and new approaches to the treatment of pancreatic cancer are desperately needed. Pharmacologic ascorbate (P-AscH(−)...
Autores principales: | Steers, Garett J., Chen, Gloria Y., O’Leary, Brianne R., Du, Juan, Van Beek, Hannah, Cullen, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137675/ https://www.ncbi.nlm.nih.gov/pubmed/35624835 http://dx.doi.org/10.3390/antiox11050971 |
Ejemplares similares
-
Epigenetic effects of pharmacologic ascorbate
por: Steers, Garett J., et al.
Publicado: (2021) -
Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
por: Du, Juan, et al.
Publicado: (2021) -
Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2023) -
Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism
por: O’Leary, Brianne R., et al.
Publicado: (2020) -
The role of mitochondria in pharmacological ascorbate-induced toxicity
por: Du, Juan, et al.
Publicado: (2022)